haloperidol decanoate has been researched along with paliperidone palmitate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R | 1 |
Goff, DC | 1 |
Buckley, PF; Byerly, M; Dominik, R; Hamer, RM; Lamberti, JS; McEvoy, JP; Ray, N; Rosenheck, RA; Stroup, TS; Swartz, MS; Wilkins, TM | 1 |
Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS | 1 |
Ide, GD; Khan, AY; Ovais, M; Salaria, S | 1 |
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J | 1 |
Tagne Nouemssi, AB | 1 |
Bareis, NA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
Ansolabehere, X; Guillon, P; Harmand, S | 1 |
1 review(s) available for haloperidol decanoate and paliperidone palmitate
Article | Year |
---|---|
Depot antipsychotics: Where do we stand?
Topics: Antipsychotic Agents; Haloperidol; Hospitalization; Humans; Medication Adherence; Paliperidone Palmitate; Schizophrenia | 2016 |
3 trial(s) available for haloperidol decanoate and paliperidone palmitate
Article | Year |
---|---|
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Schizophrenia; Treatment Failure; Treatment Outcome; Weight Gain | 2014 |
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult | 2016 |
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Progression-Free Survival; Schizophrenia; Treatment Failure; Young Adult | 2018 |
5 other study(ies) available for haloperidol decanoate and paliperidone palmitate
Article | Year |
---|---|
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden | 2014 |
Maintenance treatment with long-acting injectable antipsychotics: comparing old with new.
Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates | 2014 |
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2017 |
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability.
Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult | 2018 |
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France
.
Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia | 2019 |